Company Filing History:
Years Active: 2009-2017
Title: Innovations by Yukie Nakazawa
Introduction
Yukie Nakazawa is a prominent inventor based in Kobe, Japan. She has made significant contributions to the field of biological analysis, holding three patents that showcase her innovative spirit and technical expertise. Her work primarily focuses on improving methods for analyzing biological samples and classifying blood cells.
Latest Patents
One of her latest patents is a biological sample analyzing apparatus. This invention involves preparing an assay sample by mixing a reagent with a biological sample that may contain assay material. The apparatus collects first information related to the assay material, and if this information meets predetermined conditions, the assay material is analyzed accordingly. If not, a second set of information is collected for further analysis.
Another notable patent is a method for classifying and counting leukocytes. This method includes staining cells from a hematological sample with a fluorescent dye and measuring various light scatterings and fluorescence. The process classifies cells into groups, including leukocytes and platelet clumps, and further categorizes leukocytes into lymphocytes, monocytes, and granulocytes for accurate counting.
Career Highlights
Yukie Nakazawa is currently employed at Sysmex Corporation, a company known for its advanced diagnostic and laboratory solutions. Her role at Sysmex allows her to apply her innovative ideas in a practical setting, contributing to the development of cutting-edge medical technologies.
Collaborations
Throughout her
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.